HOME ·

01093.HK

CSPC Pharmaceutical Group (01093.HK): New Drug Application for Valsartan Levoamlodipine Maleate Tablets Accepted
Tags：
CSPC Pharmaceutical Group01093.HK
2026-06-16
CSPC Pharmaceutical Group (01093.HK): Albumin-bound Paclitaxel for Injection (II) Approved for Marketing
Tags：
CSPC Pharmaceutical Group01093.HK
2026-06-15
CSPC PHARMA(01093.HK): Phase III Study of Anistolimab Combined with HB1801 for HER2-positive Advanced Breast Cancer Meets Primary Endpoint
Tags：
CSPC PHARMA01093.HKClinical Trial
2026-06-10
CSPC PHARMA(01093.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 859.79 million, YoY decrease of 41.83%
Tags：
CSPC PHARMA01093.HK
2026-05-27
CSPC PHARMA(01093.HK): Antibody-Drug Conjugate SYS6051 Approved for Clinical Trials for Advanced Solid Tumors
Tags：
CSPC PHARMA01093.HKClinicalTrialApproval
2026-04-15
Previous12 3